ALX Oncology Announces Updates on Planned ALX148 Phase 2 Head and Neck Cancer Studies

NEXT STORY
Cytokinetics Announces Additional Results From GALACTIC-HF Presented at the 17th Global Cardiovascular Clinical Trialists
PREV STORY
Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Philips highlights AI-powered solutions focus to realize precision diagnosis at RSNA 2019

author_avatar
NASDAQ Market News

Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress

author_avatar
NASDAQ Market News

Adaptimmune Reports Second Quarter 2016 Financial Results

 - Conference call to be held today at 8:00 AM ET (1:00 PM BST) ...

author_avatar
NASDAQ Market News